Cellebrite Shareholders Approve All Proposals at Annual Meeting
Ticker: CLBT · Form: 6-K · Filed: Sep 22, 2025 · CIK: 1854587
| Field | Detail |
|---|---|
| Company | Cellebrite Di Ltd. (CLBT) |
| Form Type | 6-K |
| Filed Date | Sep 22, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
TL;DR
Cellebrite shareholders said YES to everything at the Sept 19 meeting.
AI Summary
Cellebrite DI Ltd. announced on September 22, 2025, that its shareholders approved all proposals at the annual general meeting held on September 19, 2025. The approvals were made by the requisite majority as per Israeli Companies Law and the company's articles of association.
Why It Matters
Shareholder approval of all proposals is crucial for maintaining corporate governance and enabling the company to proceed with its strategic objectives.
Risk Assessment
Risk Level: low — This filing is a routine announcement of shareholder meeting outcomes, with no new financial or strategic risks introduced.
Key Players & Entities
- Cellebrite DI Ltd. (company) — Registrant
- September 19, 2025 (date) — Date of annual general meeting
- September 22, 2025 (date) — Filing date of the report
FAQ
What type of report is this filing?
This filing is a Form 6-K, a Report of Foreign Private Issuer.
When was the annual general meeting of Cellebrite DI Ltd. held?
The annual general meeting of shareholders was held on September 19, 2025.
What was the outcome of the annual general meeting?
Shareholders approved all proposals brought before the meeting.
Under which law were the proposals approved?
The proposals were approved in accordance with the Israeli Companies Law, 5759-1999, and the Company's articles of association.
What is Cellebrite DI Ltd.'s principal executive office address?
The principal executive office is located at 94 Shlomo Shmelzer Road, Petah Tikva 4970602, Israel.
Filing Stats: 325 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2025-09-22 08:21:08
Filing Documents
- ea0258174-6k_cellebrite.htm (6-K) — 10KB
- 0001213900-25-089834.txt ( ) — 11KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellebrite DI Ltd. September 22, 2025 By: /s / Ayala Berler Shapira Ayala Berler Shapira General Counsel 2